Sat.Mar 02, 2024 - Fri.Mar 08, 2024

article thumbnail

Independent Pharmacies Continue to Face Financial Hardships as the Clock Ticks on PBM Reform

Drug Topics

As pharmacy benefit managers gain leverage to continue driving up drug prices, local pharmacies struggle to keep up and Congress has been called to act—but it might be too late

article thumbnail

Health Care Transparency Comes in Many Forms, But Is Much Needed in Patient Care

Pharmacy Times

Laws can help eliminate common barriers to transparency but are not the only way to achieve health care transparency.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Diabetes market faces disruption

Drug Store News

Ozempic and the Inflation Reduction Act represent seismic shifts in what pharmacies can offer its customers.

article thumbnail

Big hopes for schizophrenia treatment rely on a deep pipeline of new approaches

PharmaVoice

Innovation in schizophrenia has been slow, and patients are often left with few options — but pharmas contribute to a robust lineup of candidates that could improve care.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Government, Industry Leaders Address the Growing Issue of PBM Practices

Drug Topics

Health care professionals, industry leaders, and politicians gathered for a virtual roundtable to discuss the state of the PBM industry.

article thumbnail

FDA Clears First OTC Continuous Glucose Monitoring, Dexcom Stelo Glucose Biosensor System

Pharmacy Times

The continuous glucose monitoring system will be available for purchase online and without a prescription starting in summer 2024.

FDA

More Trending

article thumbnail

J&J’s growing rare disease focus brings a potential multi-use treatment to the table

PharmaVoice

The head of J&J’s autoantibody programs believes nipocalimab is unique among potential rare disease drugs because it can harness a common thread among them.

article thumbnail

Disparities in Digital Health Portal Use Persist Beyond the COVID-19 Pandemic

Drug Topics

Although the pandemic spurred a greater need and use of online health resources, certain demographics continue to report significantly low participation in digital health portals.

article thumbnail

FDA Questions Donanemab Efficacy for the Treatment of Alzheimer Disease

Pharmacy Times

The FDA is convening a committee to discuss phase 3 data after the planned action date, which delays drug availability to patients.

FDA
article thumbnail

STAT+: In stunning outcome, Amylyx’s ALS drug fails large clinical trial

STAT

Amylyx Pharmaceuticals said Friday that its treatment for ALS, called Relyvrio, failed to provide any benefit for patients in a large clinical trial — a stunning outcome that now has the company considering a voluntary withdrawal of the approved medicine from the market. “This is really hard for us, and it’s really hard for our team who care so much, but it’s so much harder for people with ALS and their families, and we have to keep that perspective,” said a so

FDA
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Could pharma’s legal attack on the IRA succeed in killing price negotiations?

PharmaVoice

An all-out blitz across U.S. courts is bolstering pharma’s goal to overturn Medicare drug price negotiations.

article thumbnail

FDA Grants Breakthrough Therapy Designation to LSD-Based Treatment for Generalized Anxiety Disorder

Drug Topics

Mind Medicine’s lysergide d-tartrate (MM120) demonstrated statistically significant and clinically meaningful improvements in anxiety symptoms in a phase 2b study.

FDA
article thumbnail

Cannabinoids show promise in acute migraine clinical trial

pharmaphorum

Inhaled cannabinoids have been shown to perform better than placebo in providing pain relief for people suffering from acute migraine in a clinical trial

article thumbnail

STAT+: Nursing home owners can hide nearly two-thirds of their profits, new study shows

STAT

A new study shows that some nursing homes are shunting the majority of their profits off of their own books and into less-visible corners of their owners’ pockets. The practice makes the nursing homes look poorer than they really are, the study’s authors wrote, which seems to bolster the industry’s arguments to Congress that it can’t meet certain proposed quality standards or handle potential Medicare payment cuts.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Black Diamond looks to outwit cancer mutations

PharmaVoice

Why the company’s novel therapeutics could have a competitive edge in a crowded cancer indication.

article thumbnail

Boehringer Ingelheim to Cap Out of Pocket Inhaler Costs at $35 Per Month

Drug Topics

The out-of-pocket price cap applies to all inhalers in the company’s portfolio and will launch on June 1, 2024.

article thumbnail

Antipsychotic Prescribing Patterns in Pediatric Patients with Major Depressive Disorder

Pharmacy Times

Findings emphasize the importance of further research on effective and safe alternative treatments for MDD in children and adolescents, specifically in patients who are refractory to nonpharmacologic treatment and/or standard of care antidepressants

article thumbnail

Florida health officials provide scant details on measles cases, worrying health experts

STAT

On Sunday, public health officials in two Michigan counties warned their residents that they may have been exposed to measles. In Wayne County , an adult who had contracted the virus abroad had been in health-related settings in Dearborn on two days last week — two urgent care clinics, a CVS pharmacy, and a hospital emergency department. Health officials in neighboring Washtenaw County issued a similar alert about a different case — also an adult, also infected abroad —

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Under new management, and under the cloud of the Change hack, HIMSS24 kicks off in Orlando next week

Fierce Healthcare

One of the largest health IT conferences, HIMSS24, will kick off in Orlando on Monday as a revamped trade show following a deal with Informa Markets last fall. | One of the largest health IT conferences, HIMSS24, will kick off in Orlando on Monday as a revamped trade show following a deal with Informa Markets last fall.

article thumbnail

HHS Says It’s Working to Help Those Impacted by Change Healthcare Cyberattack

Drug Topics

The statement says the agency is talking with CMS to initiate new flexibilities, but multiple advocacy groups have said it’s not nearly enough.

article thumbnail

President Biden Announces Desire to Cap Drug Prices for All Americans

Pharmacy Times

In the State of the Union Address, President Biden said he wants to expand the $2,000 out-of-pocket cap beyond seniors and allow Medicare to negotiate more costly drugs.

article thumbnail

Opinion: Free tuition won’t fix medicine’s diversity problem without admissions reform

STAT

Medical students at Albert Einstein School of Medicine in New York City gathered last week to hear a life-changing announcement: Ruth Gottesman revealed she would be donating $1 billion, ensuring no student at Einstein will pay tuition ever again. Leadership at Albert Einstein School of Medicine celebrated the donation as a means to attract a more diverse student body.

article thumbnail

Novo's obesity superstar Wegovy wins FDA nod to cut cardio risks in key label expansion

Fierce Pharma

Novo Nordisk’s fast-growing weight loss med Wegovy just added a new cardiovascular FDA approval to its label, likely enabling the med's superstar status to reach new levels. | The drug is the first weight loss treatment to win FDA approval to reduce the risk of severe cardiovascular outcomes, giving it an edge over rival Zepbound from Eli Lilly.

article thumbnail

Breaking: FDA Clears Dexcom Stelo, First OTC Continuous Glucose Monitor

Drug Topics

Dexcom's Stelo will be available in summer 2024.

FDA
article thumbnail

FDA Approves Tocilizumab-aazg as Biosimilar to Actemra for Multiple Indications

Pharmacy Times

Tocilizumab-aazg (Tyenne; Fresenius Kabi) is the first approved biosimilar to tocilizumab (Actemra; Genentech) as both intravenous and subcutaneous.

FDA
article thumbnail

Covid-19 increases risk of developing autoimmune disease, but vaccination helps, large study shows

STAT

Having Covid-19 increases a person’s risk of developing an autoimmune disease in the year after infection, a large study out of South Korea and Japan reports, but vaccination helps decrease that risk. Researchers used the medical records of 10 million Korean and 12 million Japanese adults to see whether those who had Covid were more likely to be diagnosed with autoimmune inflammatory rheumatic diseases, or AIRDs, in the year following infection.

article thumbnail

Mark Cuban's drug company inks first health system partnership to sell directly to Community Health Systems

Fierce Healthcare

Mark Cuban Cost Plus Drug Company has found its first national health system buyer for hospital drugs currently in short supply. | The 71-hospital for-profit is the first national health system buyer to cut a deal with the billionaire-backed generic drug maker. The companies are kicking off their partnership in CHS' Texas and Pennsylvania hospitals.

article thumbnail

FDA Approves Eye Drops to Treat Inflammation, Pain After Ocular Surgery

Drug Topics

Clobetasol propionate ophthalmic suspension 0.05% is the first ophthalmic clobetasol propionate product approved by the FDA and is the first new ophthalmic steroid on the market in over 15 years.

FDA
article thumbnail

FDA Grants Fast Track Designation For EP0031/A400 to Treat RET-Altered NSCLC

Pharmacy Times

The next-generation SRI was previously granted an Orphan Drug Designation in November 2023 and its safety and efficacy are currently being evaluated in clinical trials.

FDA
article thumbnail

STAT+: Harvard longevity scientist sparks furor with claim about reversing aging in dogs

STAT

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say.

article thumbnail

The growing uses of medicinal cannabis

Pharmaceutical Technology

Demand for medicinal cannabis is increasing globally to treat a range of illnesses and conditions.

article thumbnail

Breaking: FDA Approves Wegovy to Reduce Cardiovascular Risks in Overweight, Obesity

Drug Topics

Study results demonstrated the efficacy of semaglutide (Wegovy) in reducing cardiovascular risks in adults with overweight or obesity without diabetes.

FDA
article thumbnail

Study Analyzes Use of a Single At-Home Rapid Test for RSV, COVID-19, Flu

Pharmacy Times

The at-home test offers the availability to assess for all viruses using one tool.